1 Followers on Owler

Alzamend

is a Georgia-based biopharmaceutical company that develops and commercializes novel products for the treatment of neurodegenerative and psychiatric disorders... Read more
OverviewCompetitorsFundingNews & Insights

Alzamend

is a Georgia-based biopharmaceutical company that develops and commercializes novel products for the treatment of neurodegenerative and psychiatric disorders... Read more
Alzamend CEO: Stephan Jackman

CEO

Stephan Jackman

CEO Approval Rating

90/100

2016

PublicIndependent CompanyNASDAQALZN

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology

Annual Revenue
<$1M
Employees
4
Funding
$51.2M

News

Funding
May 14, 2024
businesswire.com
Alzamend received $24.5M in Private Placement Funding

Alzamend Competitors

1Merck
2Sanofi
3Lilly
4Celgene
5Boehringer Ingelheim
6Novartis
7Bayer
Unlock 4 + competitors

Trending Companies